{"Symbol": "PRGO", "AssetType": "Common Stock", "Name": "Perrigo Company PLC", "Description": "Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.", "CIK": "1585364", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "THE SHARP BUILDING, DUBLIN, IRELAND, D02 TY74", "OfficialSite": "https://www.perrigo.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "2001053000", "EBITDA": "795700000", "PERatio": "None", "PEGRatio": "1.142", "BookValue": "32.31", "DividendPerShare": "1.164", "DividendYield": "0.0809", "EPS": "-0.21", "RevenuePerShareTTM": "31.01", "ProfitMargin": "-0.0121", "OperatingMarginTTM": "0.0897", "ReturnOnAssetsTTM": "0.0272", "ReturnOnEquityTTM": "-0.0065", "RevenueTTM": "4281800000", "GrossProfitTTM": "1518200000", "DilutedEPSTTM": "-0.21", "QuarterlyEarningsGrowthYOY": "-0.636", "QuarterlyRevenueGrowthYOY": "-0.041", "AnalystTargetPrice": "21", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "2", "AnalystRatingHold": "3", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "5.68", "PriceToSalesRatioTTM": "0.467", "PriceToBookRatio": "0.45", "EVToRevenue": "1.218", "EVToEBITDA": "8.72", "Beta": "0.4", "52WeekHigh": "29.27", "52WeekLow": "11.91", "50DayMovingAverage": "14.13", "200DayMovingAverage": "20.91", "SharesOutstanding": "137624000", "SharesFloat": "136831000", "PercentInsiders": "0.397", "PercentInstitutions": "114.309", "DividendDate": "2025-12-16", "ExDividendDate": "2025-11-28"}